BC Platforms and Crestar Labs partner to grow cancer diagnostics and precision medicine initiatives

Modular solutions will be used to advance big data, artificial intelligence and, ultimately, patient care

BC Platforms has formed a partnership with Crestar Labs, a US-based clinical diagnostic reference laboratory offering CLIA-certified services to healthcare providers to support informed decision making around patient care.

BC Platforms will provide Crestar with its customisable, modular platform, which includes its genomic data management tools and clinical reporting hub to support Crestar’s cancer screening initiatives and pharmacogenetic reportin to help streamline and automate their offering in precision healthcare.

Jennifer Kunic, Technical Supervisor of Genetics at Crestar Labs, said: “We are delighted to partner with BC Platforms, a leader in integrating and analysing genomic and clinical data."

Our mission is to provide clinically actionable reports to providers by shifting to a molecular focus on healthcare that mirrors the field's shift to precision medicine."

"BC Platforms’ technology will provide us with the necessary framework to achieve our mission whilst enabling the flexibility to plan for new initiatives and growth by scaling up through additional modules as needed.”

Tero Silvola, CEO of BC Platforms, commented: “We look forward to working with Crestar and supporting them in growing their offering for precision medicine and cancer diagnostics."

"Our streamlined and scalable approach will enable them to manage their data and grow their initiatives with the ultimate mutual goal of improving the care of patients.”

Companies